NCT05490797 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Doumas I, Everard G, Dehem S, Lejeune T
Serious games for upper limb rehabilitation after stroke: a meta-analysis. J Neuroeng Rehabil. 2021 Jun 15;18(1):100. doi: 10.1186/s12984-021-00889-1. Review.
Jensen M, Thomalla G
Causes and Secondary Prevention of Acute Ischemic Stroke in Adults. Hamostaseologie. 2020 Feb;40(1):22-30. doi: 10.1055/s-0039-1700502. Epub 2019 Oct 24. Review.
Lanas F, Seron P
Facing the stroke burden worldwide. Lancet Glob Health. 2021 Mar;9(3):e235-e236. doi: 10.1016/S2214-109X(20)30520-9. Epub 2021 Jan 7.
Olsen TS
Arm and leg paresis as outcome predictors in stroke rehabilitation. Stroke. 1990 Feb;21(2):247-51.

Effects of Mobile Application Dexteria Fine Motor Skills on Hand Dexterity and Grip Strength in Chronic Stroke Patients

Clinical trial NCT05490797 - References